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Abstract
 
Mast cells (MCs) are centrally important in allergic inflammation of the airways, as well as in
the intestinal immune response to helminth infection. A single lineage of bone marrow (BM)-
derived progenitors emigrates from the circulation and matures into phenotypically distinct
MCs in different tissues. Because the mechanisms of MC progenitor (MCp) homing to periph-
eral tissues have not been evaluated, we used limiting dilution analysis to measure the concen-
tration of MCp in various tissues of mice deficient for candidate homing molecules. MCp were
almost completely absent in the small intestine but were present in the lung, spleen, BM, and
large intestine of 
 
 
 
7 integrin-deficient mice (on the C57BL/6 background), indicating that a
 
 
 
7 integrin is critical for homing of these cells to the small intestine. MCp concentrations were
not altered in the tissues of mice deficient in the 
 
 
 
E integrin (CD103), the 
 
 
 
2 integrin (CD18),
or the recombination activating gene (RAG)-2 gene either alone or in combination with the
interleukin (IL)-receptor common 
 
 
 
 chain. Therefore, it is the 
 
 
 
4
 
 
 
7 integrin and not the
 
 
 
E
 
 
 
7 integrin that is critical, and lymphocytes and natural killer cells play no role in directing
MCp migration under basal conditions. When MCp in BALB/c mice were eliminated with
sublethal doses of 
 
 
 
-radiation and then reconstituted with syngeneic BM, the administration of
anti-
 
 
 
4
 
 
 
7 integrin, anti-
 
 
 
4 integrin, anti-
 
 
 
7 integrin, or anti–MAdCAM-1 monoclonal anti-
bodies (mAbs) blocked the recovery of MCp in the small intestine. The blocking mAbs could
be administered as late as 4 d after BM reconstitution with optimal inhibition, implying that the
MCp must arise first in the BM, circulate in the vasculature, and then translocate into the intes-
tine. Inasmuch as MCp are preserved in the lungs of 
 
 
 
7 integrin-deficient and anti-
 
 
 
4
 
 
 
7 inte-
grin-treated mice but not in the small intestine, 
 
 
 
4
 
 
 
7 integrin is critical for tissue specific ex-
travasation for localization of MCp in the small intestine, but not the lungs.
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Introduction
 
Mast cell progenitors (MCp)
 
*
 
 arise in the bone marrow
(BM) and transit through the circulation to the peripheral
tissues where they mature (for reviews, see references 1 and
2). A single lineage of committed progenitors gives rise to
mature MCs, which can be divided into two predominant
phenotypes based on their expression of distinct secretory
granule protease arrays (3, 4). Constitutive or connective
tissue MCs (CTMCs) are found in many connective tis-
sues, especially around blood vessels and in the peritoneal
cavity, where they have been clearly implicated in the in-
nate immune response to bacteria (5, 6). T cell cytokine-
dependent reactive or mucosal MCs (MMCs) appear at
mucosal interfaces such as in the intestine, where their
numbers are amplified after a parasitic infection to mediate
rejection of certain helminths such as 
 
Trichinella spiralis
 
 (7–
10). The presence, in situ
 
,
 
 of all mature MCs requires an
intact stem cell factor (SCF)/c-
 
kit
 
 (the cell surface tyrosine
kinase receptor for SCF) pathway; animals lacking either
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Abbreviations used in this paper:
 
 BM, bone marrow; BMMC, bone mar-
row-derived MC; ICAM, intercellular adhesion molecule; MC, mast cell;
MCp, MC progenitor; MMC, reactive or mucosal MC; MNC, mononu-
clear cell; SCF, stem cell factor. 
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component possess few CTMCs and produce few reactive
MMCs in response to a helminth infection (10–15).
Studies evaluating the localization of MCp in peripheral
tissues have been limited by the fact that these cells cannot
yet be defined and enumerated on the basis of morphology.
Thus, the numbers of MCp in tissues have been determined
with limiting dilution analysis with IL-3–enriched medium
and monitoring of MC colony formation after 2 wk (16–
19). However, Rodewald et al. recently identified circulat-
ing, committed mast cell progenitors in mouse fetal blood,
and showed that their proliferation ex vivo occurred only
when the medium contained both SCF and IL-3 and not
either cytokine alone (20). These rare circulating fetal mast
cell progenitors stain weakly positive for metachromatic
granules with toluidine blue, do not have high affinity Fc
receptors for IgE (Fc
 
 
 
RI), are c-
 
kit
 
 high and Thy-1 low by
immunodetection, and do not respond to cytokines that
promote the development of other hematopoietic lineages.
The combination of SCF and IL-3 also provided greater es-
timates of MCp than the individual cytokines in BM and
blood of rats and in the mesenteric lymph nodes of mice in-
fected with a helminthic parasite (21, 22). Although earlier
analyses with media containing IL-3 in limiting dilution as-
says may not have detected all the MCp in different tissues,
they nonetheless revealed that the MCp concentration (de-
fined as the number of MCp per 10
 
6
 
 mononuclear cells
[MNCs]) in the intestine equaled that in the BM (17–19).
Because the large reservoir of MCp in intestinal tissue could
be a local source of MMCs for clearance of worms during
helminth infection, we hypothesized that there would be an
intestinal-selective homing requirement for MCp in normal
mice. And as no studies had evaluated the membrane signals
controlling the movement of BM-derived MCp into the
small intestine under normal conditions, we investigated the
integrin and c-
 
kit
 
/SCF requirements for the appearance of
these cells in the small intestine.
In this study, we optimized the limiting dilution assay by
comparing the effect of SCF, IL-3, and several other cyto-
kines in various combinations on enumeration of the con-
centration of MCp and established that SCF plus IL-3 pro-
vides the maximum MCp counts in two peripheral tissues,
the intestine and the lung. We then used this assay to ana-
lyze the concentration of MCp in the intestine of gene-dis-
rupted or naturally deficient mouse strains to identify re-
quirements for particular integrins and growth factors in
the homing of MCp to these tissues. Finally, we confirmed
the integrin requirement with irradiated, BM-reconstituted
mice and various blocking mAbs. We conclude that the
membrane signals provided to MCp by c-
 
kit
 
 and 
 
 
 
4
 
 
 
7 in-
tegrin are needed for intestinal MCp, with the later direct-
ing tissue-selective homing to the intestine.
 
Materials and Methods
 
Animals.
 
BALB/c (BALB/cAnNTac), and BALB/c–recom-
bination activating gene (RAG)-2
 
 
 
/
 
 
 
 (C.129(B6)-
 
Rag2
 
tm1
 
 N12),
and C57BL/6-RAG-2/
 
 
 
c 
 
double knockout
 
 
 
(C57BL/6J
 
 
 
 
 
C57BL/10SgSnAi)-[KO]
 
gamma C
 
-[KO]
 
Rag2
 
) mice were ob-
tained from Taconic
 
.
 
 WBB6F1/J-
 
Kit
 
W
 
/
 
Kit
 
W-v
 
 (W/Wv),
WCB6F1/J-
 
Kitl
 
Sl
 
/
 
Kitl
 
Sl-d
 
 (Sl/Sld), 
 
 
 
2 integrin chain-deficient
(B6.129S7-
 
Itgb2
 
tm1Bay
 
), 
 
 
 
7 integrin chain-deficient (C57BL/6-
 
Itgb7
 
tm1Cgn
 
) and intercellular adhesion molecule (ICAM)-1-defi-
cient (B6.129S7-
 
Icam1
 
tm1Bay
 
) mice, and the wild-type control
mice for each of these strains were obtained from The Jackson
Laboratory. The BALB/c-
 
 
 
E integrin knockout mice are main-
tained in the Dana-Farber Cancer Institute (DFCI) animal facility
and derived as described (23). All mice were 6–12 wk old when
used in these experiments. All animal protocols have been re-
viewed and approved by the DFCI Animal Care and Use Com-
mittee in accordance with the Public Health Service Policy and
provisions of the Animal Welfare Acts.
 
Media and Cytokines.
 
Cells were cultured in complete me-
dium with cytokines as previously reported for the culture of
mouse BM-derived MCs (BMMCs; references 24 and 25). The
complete medium is composed of RPMI 1640 supplemented
with 10% fetal calf serum (Sigma-Aldrich), glutamine (2 mM),
penicillin (100 U/ml), streptomycin (100 
 
 
 
g/ml), pyruvate (1
mM), nonessential amino acids, Hepes (10 mM), and 2-ME (50
 
 
 
M). Cytokines are added as indicated. Most mouse recombinant
cytokines (SCF, IL-3, IL-4, IL-9, IL-10) were prepared using
baculovirus vectors. Supernatants from infected cultures of Hi5
insect cells (Invitrogen) were tested for each cytokine by ELISA
(R&D Systems) and/or by proliferative action on IL-3–derived
BMMCs. The concentrations of SCF and IL-3 were determined
by respective comparison to recombinant mouse SCF obtained
from PeproTech and recombinant mouse IL-3 obtained from
Endogen. For the limiting dilution analysis of MCp described be-
low, SCF was used at a final concentration of 200 ng/ml and IL-3
at a final concentration of 10 ng/ml. Mouse recombinant IL-6
(PeproTech) was used at a final concentration of 10 ng/ml. The
other cytokines, IL-4, IL-9, and IL-10, were used at the concen-
tration giving maximum coproliferation of BMMCs with IL-3.
 
Sublethal Irradiation with BM Reconstitution and mAb Blocking
Protocol.
 
Animals were irradiated in groups of 12 in a Gamma-
cell-40 irradiator (Atomic Energy of Canada Limited, Ottawa,
Canada) for 4.5 min; this procedure resulted in an average expo-
sure of 5 gray (500 rads). For reconstitution, 2 h after irradiation,
the mice received intravenous injections of 10 million BM cells
that had been isolated from the femurs and tibias of syngeneic or
congenic animals, washed, and resuspended in complete medium.
The anti-
 
 
 
4 integrin mAb PS/2 (rat IgG2b-
 
 
 
, American Type
Culture Collection no. CRL-1911) and the anti-
 
 
 
4
 
 
 
7 integrin
mAb DATK32 (rat-IgG2a, American Type Culture Collection
no. HB-294) were obtained from American Type Culture Col-
lection and grown as an ascites. DATK32 was also obtained in
purified form from BD PharMingen. Purified anti–MAdCAM-1
(rat IgG2a, clone MECA-367), anti-
 
 
 
1 integrin (anti-CD29)
mAb (clones Ha2/5 [Armenian Hamster IgM] and 9EG7 [rat
IgG2a]), anti-
 
 
 
7 integrin mAb (rat IgG2a-
 
 
 
, clone FIB27), and
the Armenian hamster control mAb (anti-TNP, IgM-
 
 
 
) were
obtained from BD PharMingen. Purified anti-
 
 
 
E integrin mAb
(rat IgG2a, clone M290) was purified in-house (23, 26). An iso-
type control rat IgG2a-
 
 
 
 mAb (rat anti–mouse IgD) was pur-
chased from Biosource International. All mAbs containing so-
dium azide were dialyzed against HBSS to eliminate the azide.
Except where noted, animals received 100 
 
 
 
l of the mAb diluted
in HBSS, intraperitoneally, every other day. For the initial exper-
iments, the first injection was administered 4 h after the BM cells
had been received. Subsequently, it was found that the same re-
sults were obtained if the initial administrative was delayed until
the second day. 
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Limiting Dilution Analysis.
 
Previous investigators analyzed
MCp in the small intestine by using either the cells liberated by
agitation from the villous epithelium or by discarding this popu-
lation and digesting the residual tissue with enzymes to isolate
cells from the crypt epithelium and lamina propria (16–19).
 
 
 
To
determine the entire population of MCp, we analyzed MCp in
MNC populations isolated from the small intestine by enzymatic
digestion without discarding the villous epithelial cells. In brief,
the small intestine was removed, flushed with 30–40 ml of HBSS,
opened with scissors, rinsed in HBSS, and chopped with a scal-
pel. The tissue was transferred to 50-ml tubes, resuspended in 40
ml of complete medium containing 120 
 
 
 
g/ml collagenase
(crude type 1A; Sigma-Aldrich) and 120 
 
 
 
g/ml of collagenase/
dispase (Sigma-Aldrich), and digested with shaking for 25 min at
37
 
 
 
C. Undigested cell clumps were allowed to settle and were
subjected to a second round of enzymatic digestion. The liber-
ated cells were spun down, resuspended in 44% Percoll (Sigma-
Aldrich), overlayed on a 67% Percoll layer, and spun at 400 
 
g
 
 for
20 min at 4
 
 
 
C. The MNCs were harvested from the interface and
washed in complete medium. The viable cell counts were deter-
mined by trypan blue dye exclusion on a hemocytometer. MNCs
were isolated from the lung and large intestine by enzymatic di-
gestion in a similar manner. For the large intestine, the entire co-
lon including the cecum was taken for analysis. MNCs were ob-
tained from the BM by flushing the tibia and femurs with
complete medium and from the spleen by gentle grinding be-
tween two frosted glass slides. Cells from each of these tissues
were fractionated on Percoll gradients. MNCs were diluted seri-
ally in complete medium, and 100 
 
 
 
l of each dilution was added
to 24 wells of standard 96-well microtiter plates (Corning). Each
well then received 100 
 
 
 
l of 3,000 rad gamma-irradiated synge-
neic spleen cells as feeder cells plus cytokine(s). Feeder cell con-
centrations between 10
 
5
 
 and 10
 
6
 
 cells per well gave equivalent re-
sults; 
 
 
 
10
 
5
 
 feeder cells per well were used throughout. The
cytokine combination of SCF and IL-3 was used throughout
these studies unless otherwise indicated. In all experiments, tissues
from two or three animals were pooled for the analysis.
Cultures were incubated in a humidified 37
 
 
 
C incubator with
5% CO
 
2
 
 for 10–14 d. Colonies grown in SCF plus IL-3 could be
detected after 10–12 d, while those developed in IL-3 or in SCF
plus IL-6 plus IL-10 (Triad) were always detected after 12–14 d
because of their slower growth rates. Other cytokine combina-
tions tested, SCF plus IL-4 or IL-9 or IL-10 or all four cytokines
together, did not result in the formation of increased numbers of
MCp colonies from intestinal MNCs. Because several combina-
tions of IL-3 plus the other cytokines also did not give greater es-
timations of the MCp concentration than that achieved with SCF
plus IL-3, SCF plus IL-3 was the cytokine combination used in
all experiments unless otherwise indicated. MCp colonies were
detected with an inverted microscope and were easily distin-
guished as nonadherent, medium sized cells (16–18). The pres-
ence of MCp colonies in wells scored as positive for MC growth
was validated histologically for all conditions with toluidine blue
and/or chloroacetate esterase staining of cytocentrifuge prepara-
tions of the individual wells (4). Several wells scored as negative
for MC growth but containing other colonies were also initially
evaluated histologically to confirm the ability to distinguish MCp
colonies from those of other cells. Several methods for determin-
ing the concentration of MCp in the isolated MNC preparations
were compared. The L-Calc™ computer program (Stem Cell
Technologies Inc.) is commercially available. Also, using the
trend function in commercially available spreadsheet programs,
the number of MNCs plated that results in 37% of the wells neg-
ative for a MCp colony was estimated from the plot of the log of
the fraction of nonresponding cultures versus the cell number
plated. Finally, as described in Crapper and Schrader (18), the
concentration can be estimated by dividing the log of the fraction
of nonresponding cultures by the cell number plated per well. All
three methods gave very similar results (variation 
 
 
 
10% in three
different comparisons), and thus we routinely estimated the MCp
concentration (MCp per 10
 
6
 
 MNCs) in the various tissues with
the trend function in Microsoft Excel™. The percent inhibition
was calculated with the following formula: 100 
 
 
 
 [100 
 
 
 
 (exper-
imental MCp concentration/control MCp concentration)].
 
Results
 
Comparison of MCp Concentrations in the Tissues of
C57BL/6 and BALB/c Mouse Strains Cultured with Different
Cytokine Combinations.
 
As an initial assessment of cyto-
kines to be used for the optimal analysis of tissue MCp con-
centrations, we compared IL-3 alone, the cytokine triad of
SCF plus IL-6 plus IL-10, and SCF plus IL-3. The cytokine
triad is active on early Sca1
 
 
 
 stem cells and generates less
mature cells, termed early metamastocytes, from BM than
IL-3 alone (25), while SCF plus IL-3 is active on fetal blood
promastocytes that do not respond to either cytokine alone
(20). We determined the MCp concentration in the
C57BL/6 (BL/6) and BALB/c mouse strains, which are the
background strains of the various genetic mutants used in
these studies. Similar concentrations of MCp were found in
the intestine of both strains when the MNCs were cultured
in either SCF plus IL-6 plus IL-10 or IL-3 alone (Fig. 1).
However, SCF plus IL-3 provided a significantly greater
concentration of MCp from the intestine of BALB/c mice
Figure 1. Concentrations of MCp in the small intestine and lung of
C57BL/6 (white bars) and BALB/c (black bars) mice. MNCs were isolated
from the intestine or the lung of normal C57BL/6J or BALB/c mice by en-
zymatic digestion. The MCp concentration is the number of MCp per 106
MNCs as determined by limiting dilution analysis with the cytokine com-
binations of SCF plus IL-3, IL-3 alone, or SCF plus IL-6 plus IL-10 (Triad).
The values are the means   SEM for five experiments. ND, not done.1246  4 7 Integrin in Mast Cell Progenitor Homing
(P   0.009), but not from BL/6 mice (P   0.5), than that
obtained with IL-3 or SCF plus IL-6 plus IL-10. The con-
centration of intestinal MCp detected with SCF plus IL-3 is
about threefold greater than in BM of BALB/c mice (3,057  
757 versus 924   155 MCp/106 MNCs, mean   SEM,
n   5 and n   6, respectively), but the two concentrations
are equivalent in BL/6 mice (876   223 versus 992   57
MCp/106 MNCs, n   5 and n   2, respectively). None or
very few colonies were detected in cultures containing SCF
alone. In contrast to the large concentration of intestinal
MCp, the concentration of MCp in the lung is 20–50-fold
less in both mouse strains (Fig. 1, note different scale), al-
though, again, the BALB/c mice show many more SCF
plus IL-3 responsive progenitors in this tissue than does the
BL/6 strain. The concentration of IL-3 responsive progeni-
tors is comparable for the lung of both strains and similar to
the concentration of SCF plus IL-3 responsive progenitors
in the BL/6 strain. In the BALB/c mice, comparable con-
centrations of MCp are detectable with SCF plus IL-6 plus
IL-10 or SCF plus IL-3 in the lung. As SCF plus IL-3 was
optimal for the BALB/c strain and sufficient for the BL/6
strain, this combination was used for all subsequent assays of
tissue MCp concentrations.
Role of c-Kit and SCF on Intestinal MCp Concentrations.
W/Wv and Sl/Sld mice have  1% of the number of mature
tissue MCs, constitutive or reactive, found in wild-type
control mice and yet provide comparable numbers of IL-3
developed, BM-derived MCPs of an identical protease phe-
notype (14, 15, 27, 28). However, their intestinal MCp
concentrations had not been assessed. Because the W/Wv
mice have a mutant c-kit, we used both SCF plus IL-3 and
IL-3 alone to analyze the concentration of tissue MCp in
both strains. The response to IL-3 alone in the wild-type
controls was the same as that to SCF plus IL-3 in all the tis-
sues studied (Table I), likely reflecting their hemizygous BL/6
background. The BM concentrations of MCp for the W/Wv
mice were similar to those of their wild-type controls (28),
whereas the Sl/Sld mice had about one-half the BM MCp
concentration of their controls (Table I). No intestinal MCp
were detected for either mutant strain, a finding compatible
with a defect in translocation or survival of peripheral tissue-
localized MCp in both strains. The negative data were based
on plating more than 4   106 MNCs and 2   106 MNCs
for the W/Wv and Sl/Sld mouse strains, respectively, with-
out the appearance of a single MCp colony. These results
are similar to those reported for the intestine of Ws/Ws
(c-kit deficient) rats (21) and more dramatic than those re-
ported for the intestine of Wf/Wf mice (18). In contrast, the
spleen, with an open vascular system as well as an extramed-
ullar hematopoietic potential, contained MCp, but at a level
below that of their wild-type controls.
Role of  E,  2, and  7 Integrins on Intestinal MCp Concen-
trations. Mice with various gene disruptions have been
used to establish the role of various integrins, particularly
 7 and  2 integrins, in the trafficking of T cells into the
gut-associated lymphoid tissues (23, 29–31). We took ad-
vantage of such mice to investigate the role of  E,  7, and
 2 integrins on MCp trafficking to the intestine and lung.
The  7 integrin chain deficiency resulted in a virtual abla-
tion of the MCp reservoir in the small intestine without a
Figure 2. Concentrations of
MCp in the small intestine, lung,
spleen, and BM of wild-type
(C57BL/6,   / , white bars)
control and  7 integrin-deficient
mice ( / , black bars) evalu-
ated in parallel. The data are
from three separate experiments
and the values are the mean  
SEM. SCF plus IL-3 was used to
determine MCp concentration,
expressed as the number of
MCp/106 MNCs.
Table I. Concentrations of MCp in Tissues of MC-deficient Mice
MCp/106 MNCs (SEM)
Tissue
Strain BM Intestine Spleen
SCF plus IL-3-responsive MCp
WCB6F1 ( / ) 345 (90) 939 (241) 47
WCB6F1-KitlSl/KitlSl-d (Sl/Sld) 145 (88) 0 (0) 23
WBB6F1 ( / ) 198 739 39
WBB6F1-KitW/KitW-v (W/Wv) 224 (18) 0 (0) 13
IL-3-responsive MCp
WCB6F1 ( / ) 311 (2) 878 (352) 81
WCB6F1-KitlSl/KitlSl-d (Sl/Sld) 113 (24) 0 (0) 14
WBB6F1 ( / ) 188 (13) 583 (127) 30 (13)
WBB6F1-KitW/KitW-v (W/Wv) 246 (33) 0 (0) 11 (1)
The values are the average MCp concentration for the indicated tissue.
The intestine refers to the small intestine only. Numbers in parentheses
are the standard error of the mean (same as 1/2 range) from two
experiments; numbers standing alone are from a single experiment. For
the mutant strains, the historical designation is provided in parentheses.1247 Gurish et al.
reduction in the lung, spleen, or BM MCp concentrations
(Fig. 2). MCp concentrations in the large intestine were
similar in both strains as well (282 and 392 MCp/106
MNCs for BL/6 and  7 integrin-deficient mice, respec-
tively, in a single analysis). The average concentration of
MCp in the small intestines of  7 integrin-deficient mice
was only 26   22 MCp/106 MNCs (mean   SEM, n  
3), whereas BL/6 mice analyzed in parallel had an average
of 1,440   770 MCp/106 MNCs. The  7 integrin chain
is found associated with the  4 (CD49d) and the  E
(CD103) integrin chains (23, 26, 29, 32). Unlike the defi-
ciency in the  7 integrin chain, a deficiency in the  E in-
tegrin chain had no effect on intestinal MCp concentra-
tions (Table II). Normal concentrations of MCp also were
observed in the lung and BM of these animals. Normal
concentrations of MCp were observed in the intestine and
BM in both  2 integrin-deficient and ICAM-1–deficient
mice as well (Table II). Thus, under basal conditions, in-
testinal MCp trafficking requires the  4 7 integrin but
apparently not the  E 7 or  2 integrins.
The selective deficiency of intestinal MCp in mice with
a disruption of the  7 integrin gene could reflect a direct
impairment of extravasation of these cells or be indirect
due to an altered availability of another cell type. We ad-
dressed this issue with mice lacking all mature lymphocytes
and NK cells, available as RAG-2 plus IL-receptor com-
mon   chain double-deficient mice (RAG-2/ c / ; refer-
ences 33 and 34). RAG-2/ c-deficient mice have normal
or increased concentrations of MCp in the small intestine,
the lung, and the BM compared with the BL/6 control
mice (Fig. 3). Mice deficient in only RAG-2 (on the
BALB/c background), which lack mature lymphocytes,
also had increased concentrations of MCp when compared
with their BALB/c controls (data not shown). Therefore,
the presence of MCp in peripheral tissues is not dependent
on the availability of lymphocytes or NK cells.
Blocking of Intestinal MCp Reconstitution by Anti-integrin
mAbs. Kitamura and others have demonstrated that BM
reconstitutes the MC populations in W/Wv MC-deficient
mice and that BM MCp are very sensitive to gamma-irra-
diation (11, 15, 35, 36). Thus, we evaluated the loss and re-
covery of MCp in the BM, intestine, and lung of BALB/c
mice exposed to sublethal irradiation, with and without re-
constitution by administration of syngeneic BM cells. In
the absence of BM reconstitution, the recovery of the
MCp concentration in the small intestine is slow (Fig. 4).
With BM reconstitution, the recovery of intestinal MCp
reaches 20% by day 7, 40% by day 9, and normal levels by
day 11 (Fig. 4). The recovery of the MCp concentration in
the BM of the reconstituted mice occurs even more rap-
idly, with normal levels obtained 4 d after irradiation, the
earliest time point evaluated (data not shown, n   3). The
levels of MCp were  50% of normal in the lung 7 d after
sublethal irradiation and BM reconstitution (data not
shown, n   2). The partial recovery of MCp concentra-
tions in the intestine and lung 7–9 d after sublethal irradia-
tion and BM reconstitution provided a reference against
which the effect of administering blocking mAbs to various
integrins could be quantitated.
The high affinity mAb PS/2 (rat IgG2b) recognizes and
blocks the binding function of both  4 1 and  4 7 inte-
grins, whereas the mAb DATK32 (rat IgG2a) recognizes a
combinatorial determinate and blocks binding only by the
Table II. Concentrations of MCp in Tissues of  E and  2 
Integrin-deficient and ICAM-1–deficient Mice
MCp/106 MNCs
Strain BM Intestine Lung
C57BL/6J ( / ) 557 980 22
B6.129S7-Itgb2 ( 2 integrin / ) 305 740 N.D.
B6.129S4-Icam1 (ICAM-1 / ) 414 904 N.D.
BALB/c ( / ) 924 3,051 149
BALB/c-CD103 /  ( E integrin / ) 998 3,207 126
The values are the MCp concentration in the listed tissues from the
indicated strains of mice. The numbers from the E integrin-deficient
mice are the average of four experiments for the BM and small intestine
and three experiments for the lung. The values for the  /  animals are
those reported in Fig. 1 as MCp concentrations obtained with SCF plus
IL-3. The values for the  2 integrin-deficient, and ICAM-1–deficient
mice are from a single experiment. N.D., not done.
Figure 3. Concentrations of MCp in the small intestine,
lung, and BM of wild-type (C57BL/6,  / , white bars)
controls and RAG-2/IL-receptor common  -chain ( c)
double-deficient mice ( / , black bars). The data are the
mean   1/2 range of MCp/106 MNCs from two experi-
ments using SCF plus IL-3 in which concentrations in
wild-type and deficient mice were determined in parallel.1248  4 7 Integrin in Mast Cell Progenitor Homing
 4 7 integrin (32, 37). The dose-dependent effect of ad-
ministering anti- 4 (PS/2) and anti- 4 7 (DATK32) inte-
grin mAbs on the recovery of MCp in the intestine was
determined with the sublethal irradiation and BM reconsti-
tution procedure and compared with the effect of a control
mAb, rat anti–mouse IgD (rat IgG2a). All doses greater
than 1  g (given intraperitoneally every other day) of ei-
ther the anti- 4 or the anti- 4 7 integrin mAb caused
 70% inhibition of MCp reconstitution (Fig. 5). As a dose
of 30  g of either mAb consistently gave  70% inhibition,
this dose was chosen for subsequent experiments. No effect
on BM MCp concentrations was observed in mice given
either PS/2 or DATK32 (data not shown).
Because the recovery of MCp in recipient BM preceded
recovery in the intestine, the effectiveness of delaying the in-
troduction of the blocking mAb on the recovery of intestinal
MCp was determined. The blocking mAb to the combina-
torial epitope of  4 7 integrin (DATK32) was fully effective
when the first dose was delayed to day 2 or even day 4 and
was partially effective with a single dose on day 6 as com-
pared with the initial administration on day 0 when MCp
concentrations were assessed on day 7 (Fig. 6). Comparable
inhibition also was obtained in one experiment in which in-
testinal MCp were quantitated on day 11 after sublethal irra-
diation and BM reconstitution and the administration of
anti- 4 7 integrin mAb was initiated on day 2 or 6. The ad-
ministration of DATK32 beginning on day 2 gave 92% inhi-
bition, and on day 6 gave 76% inhibition relative to the ef-
fect of an irrelevant isotype-matched mAb given beginning
on day 2. As the administration of blocking mAb could be
delayed for several days, the reconstituting syngeneic cells re-
quired conditioning in the recipient BM for lineage devel-
opment before distribution of MCp to the intestine.
To evaluate the integrin specificity of MCp recovery in
the intestine after sublethal irradiation and BM reconstitu-
tion, we compared the inhibition obtained with anti- 7 in-
tegrin (FIB27, rat IgG2a), anti- E integrin (M290, rat
IgG2a), or anti- 1 integrin (9EG7, rat IgG2a) mAb to that
obtained with the isotype matched anti- 4 7 integrin
(DATK32) mAb. The MCp concentration was evaluated 7
or 8 d after sublethal irradiation and BM reconstitution
(Fig. 7). The anti- 4 7 integrin mAb DATK32 blocked
MCp reconstitution in the intestine by 74   5% (mean  
Figure 4. Recovery of MCp in the small intestine of BALB/c mice af-
ter sublethal irradiation with (filled circles) or without (open circles) BM
reconstitution (BMR). Values for MCp concentrations without BM re-
constitution are the mean   1/2 range of two experiments. Values for an-
imals receiving BM reconstitution are the mean   SEM of the following
number of experiments: day 7, n   12; day 8, n   9; day 9, n   6; day 11,
n   5; day 14, n   4. MCp concentrations were determined with SCF
plus IL-3. The shaded area represents the mean   SEM concentration of
MCp in normal BALB/c small intestine (from Fig. 1, SCF plus IL-3).
Figure 5. Effect of the blocking anti-integrin mAb, PS/2 (anti- 4, rat
IgG2b, open circles) and DATK32 (anti- 4 7, rat IgG2a, filled circles), on
the recovery of MCp in the small intestine of BALB/c mice. MCp con-
centrations were determined 9 d after sublethal irradiation and BM recon-
stitution and are expressed as the percent inhibition of MCp concentrations
in the intestine relative to mice treated with a control mAb (rat anti–mouse
IgD, IgG2a) or HBSS. mAb was diluted in HBSS and administered intra-
peritoneally every other day starting 4 h after BM reconstitution. The re-
sults are the average inhibition for two or three experiments with the fol-
lowing n values: For PS/2, 100  g, n   2; 30  g, n   3, 10  g and 1  g,
n   1; for DATK32, 30  g, n   3, for 10  g, 1  g, and 0.1  g, n   1.
The average concentration of intestinal MCp for mice given the control
mAb or HBSS was 903   311 MCp/106 MNCs (mean   SEM, n   5).
Figure 6. Effect of delaying the time of initial administration of the
blocking mAb DATK32 (anti- 4 7 integrin) on the recovery of MCp
in the small intestine of BALB/c mice. The MCp concentrations were
determined 7 d after sublethal irradiation and BM reconstitution and are
expressed as the percent inhibition of MCp concentrations in the intes-
tine relative to the mice treated with the isotype-matched rat anti–
mouse IgD mAb. The control mice had an average MCp concentration
of 632   206 MCp/106 MNCs (mean   SEM, n   6). Experimental
values are the mean   SEM of four (day 0 and day 2) or two (day 4 and
day 6) experiments.1249 Gurish et al.
SEM, n   7), and the anti- 7 integrin mAb blocked recon-
stitution by 53   14% (n   3). In contrast, neither of the
isotype-matched mAbs reacting with  E (CD103) or  1
(CD29) integrins had any significant effect on MCp recov-
ery in the intestine (11   16% inhibition, n   3, and 5  
8% inhibition, n   4, respectively). Similar results were also
obtained with the hamster anti–mouse  1 integrin mAb,
Ha2/5 (hamster IgM, mean % inhibition   SEM    7  
19%, n   4). The inhibition obtained with DATK32 was
statistically significant compared with that obtained with
M290 and 9EG7 (P   0.001), whereas the inhibition ob-
tained with FIB27 was significantly different from that ob-
tained with 9EG7 (P   0.026), as analyzed by the Student’s
t test. As MAdCAM-1 is a high endothelial cell ligand for
 4 7 integrin in the small intestine, we also examined the
blocking of intestinal MCp recovery by anti–MAdCAM-1
mAb (MECA-367). After sublethal irradiation and BM re-
constitution, administration of anti–MAdCAM-1 mAb be-
ginning on day 2, with analysis on day 7, revealed a 45  
5% suppression (mean   SEM, n   3) compared with mice
receiving an isotype-matched control mAb.
The evidence that anti- 4 7 or anti- 4 integrin, in
contradistinction to the findings for  E or  1 integrins,
blocked reconstitution of MCp in the small intestine led to
a parallel assessment of the role of  4 7 integrin for hom-
ing of MCp to the lung. Whereas mice receiving anti-
 4 7 integrin restored only 30.9   9.6% (mean   SEM)
of their MCp in the small intestine, the lung concentration
of MCp was increased to 275.1   57.5% relative to iso-
type-matched control mAb injected mice in four separate
experiments assayed on day 7 after sublethal irradiation and
BM reconstitution (Fig. 8).
Discussion
To facilitate our study of the mechanisms of MCp local-
ization to tissues, we sought to identify conditions of culture
that would maximize the proliferation of MCp dispersed
from tissues. It was recently reported that the combination
of SCF and IL-3 was superior to either cytokine alone for
the detection, by ex vivo culture, of fetal MC lineage pro-
genitors isolated from 14.5-d-old embryos or MCp isolated
from tissues of helminth-infected rodents (20–22). We
found that SCF plus IL-3 induced the growth of  sixfold
more MCp than IL-3 alone in the intestines of BALB/c
mice, but similar concentrations in the intestines of C57BL/6
mice (Fig. 1). SCF plus IL-3 also induced the growth of
more MCp colonies from the intestines than SCF plus IL-6
plus IL-10, a cytokine triad that induces the proliferation of
progenitors from the BM that are less mature than the cells
induced by IL-3 alone (25). In comparison to the intestines,
there were dramatically fewer MCp in lung tissue of both
strains after culture with SCF plus IL-3. Further, SCF plus
IL-6 plus IL-10 detected MCp concentrations in the lungs
of BALB/c mice that were almost equal to those obtained
by culture with SCF plus IL-3. The different cytokine-
driven proliferation characteristics for MCp in these two tis-
sues and between these two strains of mice likely indicates
that there is different tissue-directed maturation and/or a
different tissue-selective homing requirement for localiza-
tion and differentiation of the common circulating MCp.
As an initial approach to characterize the integrin re-
quirements for MCp homing and retention in the small in-
testine and other peripheral tissues, MCp concentrations
were evaluated in mice that lacked specific adhesion mole-
cules due to targeted disruptions. These studies focused on
adhesion molecules that have been implicated in T cell
homing or localization to the small intestine, such as the
 4 7,  E 7, and  L 2 integrins, which bind to MAd-
CAM-1, E-cadherin, and ICAM-1, 2, and 3, respectively
(23, 26, 29–32, 37–41). In  7 integrin gene-disrupted
mice, there was a marked reduction in the small intestinal
MCp concentration, to less than 5% of that in wild-type
C57BL/6 control mice, while the MCp concentration was
Figure 7. Comparison of the inhibition by mAb to  4 7,  7,  E, or
 1 integrins of the recovery of MCp in the small intestine of BALB/c
mice. Animals received 30  g of the indicated mAb, DATK32, FIB27,
M290, or 9EG7, directed against  4 7,  7,  E, or  1 integrins, respec-
tively, starting 0 or 2 d after sublethal irradiation and BM reconstitution.
Values represent the mean   SEM percent inhibition relative to control
animals treated in parallel. MCp concentrations were analyzed 7 or 8 d af-
ter sublethal irradiation and BM reconstitution. Means are from seven
(DATK32), three (FIB27, M290), or four (9EG7) experiments. The
mean MCp concentration for the control mice was 622   65 MCp/106
MNCs (mean   SEM). Asterisks indicate statistically significant inhibi-
tion relative to mice injected with anti- 1 integrin mAb (P   0.03).
Figure 8. Inhibition  by mAb to
 4 7 integrin of the recovery of
MCp in the small intestine of
BALB/c mice is accompanied by in-
creased MCp in the lung. Animals
received 30  g of the mAb,
DATK32, directed against the  4 7
integrin, or a control injection of
HBSS or isotype matched rat mAb,
starting 2 d after sublethal irradiation
and BM reconstitution. Values rep-
resent the mean   SEM (n   4) of
the MCp concentration in the indi-
cated tissues expressed as a percent-
age of the value obtained from con-
trol animals treated in parallel. MCp
concentrations were analyzed 7 d af-
ter sublethal irradiation and BM reconstitution. The MCp concentrations
for the control mice were 1,068   390 and 252   51 MCp/106 MNCs
(mean   SEM) for the intestine and lung, respectively.1250  4 7 Integrin in Mast Cell Progenitor Homing
preserved in their BM, spleen, lung (Fig. 2), and large in-
testine. In contrast, disruption of the  E integrin gene, the
 2 integrin gene, or the ICAM-l gene had no effect on the
concentration of MCp in the small intestine (Table II). As
 E integrin deficiency did not result in altered MCp num-
bers, it seemed highly likely that  4 7, rather than  E 7,
was the integrin required for the localization of MCp to
the small intestine. However, the maturation of reactive
MMCs in the intestine requires T cells (7–10, 42–44) that
are also dramatically diminished in number in the  7 inte-
grin-deficient mice (29, 44). Therefore, it was important to
determine if MCp localization also required T cells, in
which case the impact of  7 integrin chain deficiency on
MCp concentrations might be an indirect one due to the
concurrent loss of intestinal T cells in these animals. In
contrast to the impact of  7 integrin chain deficiency, the
MCp concentrations were actually increased in the small
intestine and lung of RAG-2/ c and RAG-2 gene dis-
rupted mice compared with their wild-type controls,
C57BL/6 or BALB/c mice, respectively (Fig. 3). Thus,
MCp localization in the intestine did not depend on the
presence of T (or B) lymphocytes or NK cells, and the im-
pact of  7 integrin chain deficiency on MCp localization
to the small intestine is a direct effect on this cell. More-
over, because  7 integrin chain deficiency did not affect
the concentration of MCp in the BM, large intestine, or
lung, these findings indicate that  4 7 integrin plays a se-
lective role in MCp cell homing to the small intestine.
The evidence from gene-disrupted mice that the  4 7
integrin was needed for the presence of intestinal MCp did
not establish that its role was directed to the transendothe-
lial movement of lineage progenitors out of the vasculature
and into the intestine. Therefore, we turned to the use of
blocking mAbs in animals rendered deficient in MCp by
sublethal irradiation and undergoing reconstitution in the
BM and at peripheral sites by the administration of synge-
neic BM. The small intestinal (Fig. 4) and lung MCp were
highly radiosensitive, as shown previously for BM MCp
(36). Spontaneous recovery after sublethal irradiation re-
quired more than 14 d for BM (data not shown), and the
peripheral tissues reached only one-third that of the
BALB/c control mice at d 14 (Fig. 4). After the administra-
tion of syngeneic BM, the full recovery of MCp concen-
trations in recipient BM occurred by d 4, at which time
neither intestine nor lung had detectable MCp. 7–9 d after
sublethal irradiation and BM reconstitution, recovery of in-
testinal and lung MCp concentrations were consistent and
in the 20–50% range (Fig. 4). The administration of anti-
integrin mAb either to the  4 integrin chain or to a combi-
natorial epitope on  4 7 integrin inhibited this recovery
by  70% (Figs. 5–8), even when the initial administration
was delayed until the fourth day after sublethal irradiation
and BM reconstitution (Fig. 6), a time when recipient BM
was fully recovered. This finding indicates that progenitors
suitable for translocation to the intestine via the vasculature
were first developed or conditioned in the recipient BM.
The inhibition of intestinal homing of MCp by anti-
 4 7 integrin mAb was substantial at both day 7 and even
at day 11 with every other day administration of blocking
mAb from day 2 to the day before the assay. In contrast,
mAb to  E or  1 integrin subunits had no effect (Fig. 7),
indicating that homing to the intestine requires  4 7 inte-
grin and not  4 1 or  E 7 integrins. That mAbs to  4 7
integrin and to MAdCAM-1 each inhibited reconstitution
of MCp in the small intestine, whereas mAb to  E was
without effect (Fig. 7), identifies a critical pairing for hom-
ing to this tissue. The inhibition of recovery of intestinal
MCp by mAb to MAdCAM-1 after sublethal irradiation
and BM reconstitution also implies that the inhibitory ef-
fect obtained with mAb to the  4 7 integrin can be attrib-
uted to blocking transmigration out of the vasculature
rather than to cytolysis or sequestration. This interpretation
would also be compatible with the findings of a threefold
increment in pulmonary MCp in association with blocking
of intestinal MCp recovery by mAb to  4 7 integrin (Fig.
8). The deficiency in small intestinal but not lung or large
intestinal MCp in  7-null mice and the failure of mAb to
 4 7 integrin to inhibit lung MCp recovery indicates that
the movement of MCp into these two peripheral tissues is
regulated differently than for the small intestine. Further-
more, these findings indicate that circulating MCp have a
common phenotype and that in the absence of elicited in-
flammation, selection is based on tissue-regulated constitu-
tive differences. Finally, the normal concentrations of MCp
in the small intestine of  2 integrin and ICAM-1 null mice
(Table II) distinguish the homing of MCp from that of in-
traepithelial T cells (31).
The critical role of the  4 7 integrin-dependent MCp
reservoir is evident from the impaired intestinal mastocytosis
and clearance of the T. spiralis worm burden recently re-
ported for the  7–integrin chain-deficient animals (44).
That a delayed, attenuated MC amplification subsequently
occurred in the intestine after infection with T. spiralis in
spite of the paucity of resident MCp demonstrated by us
likely reflects recruitment via vascular changes associated
with the inflammatory response. The T cell recruitment to
the intestine was also attenuated (44), revealing an  4 7 in-
tegrin requirement previously recognized through other
studies (26, 29, 30, 32, 37–41). Because our analysis does
not reveal any T cell requirement for homing of MCp to
peripheral tissues (Fig. 3), we interpret the T. spiralis chal-
lenge study in  7 integrin-deficient mice to support the crit-
ical role of the physiologic homing of  4 7 integrin-positive
MCp to the small intestine for their subsequent T cell–driven
maturation. This homing of MCp poised to respond to an
appropriate inflammatory stimulus in this tissue is unlike the
T cell localization to the lamina propria that primarily in-
volves recruitment of activated cells (30–32, 37–41).
Like the  7 integrin-deficient mice, mice with a herita-
ble disruption of c-kit or its ligand, SCF, have reduced
concentrations of intestinal MCp, despite substantial con-
centrations of MCp in their BM (Table I). Thus, a func-
tional c-kit also is required for the localization of intestinal
MCp. Based upon in vitro, in situ, and ex vivo studies, the
activities of the c-kit/SCF pathway include developmental
maturation, chemotaxis, adhesion, and cytoprotection of1251 Gurish et al.
mature MC in peripheral tissues and/or BMMCs (45–51).
In particular, BMMCs derived from W/Wv mice lack a
fully functional c-kit but still have a chemotactic response
to SCF (48). Thus, soluble SCF could send a translocation
signal to W/Wv MCp. However, the injection of W/Wv
mice with SCF does not result in the appearance of local
mature MC in these mice, suggesting that SCF is required
for a function other than the induction of migration of
MCp (51). Although cutaneous application of phorbol 12-
myristate 13-acetate (52) or intestinal helminthic infection
(10–12) can elicit local mature MC in the c-kit/SCF-defi-
cient mice, the numbers are minimal relative to normal
mice. Taken together, these findings suggest that c-kit/
SCF-deficient mice lack intestinal MCp because SCF pro-
vides a signal required for the survival of MCp in this tissue
and therefore the maturation of any translocated MCp is
not possible. Thus, the physiologic intestinal reservoir of
MCp requires both an intact cytoprotective c-kit/SCF
pathway and a tissue-selective homing of MCp that express
 4 7 integrin.
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